NOVEL ANTIBODIES FOR HIV AND METHODS OF MAKING AND USING SAME Read more about NOVEL ANTIBODIES FOR HIV AND METHODS OF MAKING AND USING SAME US Application 63/422,250Filed on 2022-11-03
VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS Read more about VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS US Application 63/517,246Filed on 2023-08-02
VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS Read more about VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS US Application 63/419,637Filed on 2022-10-26
EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES Read more about EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES US Application 63/476,889Filed on 2022-12-22
NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US Application 63/409,016Filed on 2022-09-22
Compositions And Methods For Treating Malaria Read more about Compositions And Methods For Treating Malaria US Application 63/140,308Filed on 2021-01-22
EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY Read more about EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY US Application 63/482,143Filed on 2023-01-30
Novel Compositions Of Matter Comprising Pfs230 Malaria Vaccine Antigens And Anti-Pfs230 Monoclonal Antibodies And Their Use Read more about Novel Compositions Of Matter Comprising Pfs230 Malaria Vaccine Antigens And Anti-Pfs230 Monoclonal Antibodies And Their Use US Application 63/368,739Filed on 2022-07-18
Engineered SARS-CoV-2 Antibodies With Increased Neutralization Breadth Read more about Engineered SARS-CoV-2 Antibodies With Increased Neutralization Breadth US Application 63/404,473Filed on 2022-09-07
Multi Protein Nanoparticle Monkeypox Vaccine Read more about Multi Protein Nanoparticle Monkeypox Vaccine US Application 63/402,702Filed on 2022-08-31